Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
MOA Magnifiers
Trabectedin: a DNA-Binding Agent That Covalently Interacts with the Minor Groove of the DNA Double Helix
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Necitumumab: an Epidermal Growth Factor Receptor Antibody
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Bavituximab: a Novel, Investigational Immunotherapy Agent Targeting Phosphatidylserine in the Vasculature of the Tumor Microenvironment
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Alectinib: an Anaplastic Lymphoma Kinase (ALK) Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Lenvatinib: a Receptor Tyrosine Kinase Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Abemaciclib (LY2835219): a Dual Inhibitor of CDK4 and CDK6
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Venetoclax (ABT-199): a Selective Inhibitor of B-Cell Lymphoma-2
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Ruxolitinib: a Kinase Inhibitor That Inhibits Overactive JAK Pathway Signaling
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Panobinostat: a Histone Deacetylase Inhibitor
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Idelalisib: a Selective Inhibitor of the Delta Isoform of Phosphatidylinositol 3-Kinase
MOA Magnifiers
Mechanism of Action Magnifier – 2016 Desk Reference
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma